Tag Archives: Mallinckrodt

August, 2018

December, 2017

  • 26 December

    Mallinckrodt to Acquire Sucampo Pharmaceuticals for $1.2 Billion

    STAINES-UPON-THAMES, United Kingdom and ROCKVILLE, Md., Dec. 26, 2017 /PRNewswire/ — Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutical company, and Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP), a global biopharmaceutical company, today announced that they have entered into an agreement under which Mallinckrodt will acquire Sucampo, including its commercial and …

November, 2017

  • 3 November

    Mallinckrodt to Acquire Ocera Therapeutics for up to $117 Million

    STAINES-UPON-THAMES, United Kingdom, and REDWOOD CITY, Calif., Nov. 2, 2017 /PRNewswire/ — Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutical company, and Ocera Therapeutics, Inc. (NASDAQ: OCRX), today announced that they have entered into an agreement under which Mallinckrodt will acquire Ocera, a clinical stage biopharmaceutical company focused on …

October, 2017

August, 2017

  • 4 August

    Mallinckrodt to Acquire InfaCare Pharmaceutical

    STAINES-UPON-THAMES, United Kingdom, Aug. 4, 2017 /PR Newswire/ — Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutical company, and InfaCare Pharmaceutical Corporation today announced that they have entered into an agreement under which Mallinckrodt will acquire InfaCare, a privately held specialty pharmaceutical company focused on development and commercialization of …

August, 2016

November, 2015